Document is current
Any future updates will be listed below
-
Authors
Buhigas, Claudia
Warren, Anne Y.
Leung, Wing-Kit
Whitaker, Hayley C.
Luxton, Hayley J.
Hawkins, Steve
Kay, Jonathan
Butler, Adam
Xu, Yaobo
Woodcock, Dan J.
Merson, Sue
Frame, Fiona M.
Sahli, Atef
Abascal, Federico
,
Gihawi, Abraham
Lambert, Adam
Thompson, Alan
Futreal, Andrew
Menzies, Andrew
Baddage, Anne
Ng, Anthony
Sahil, Atef
Kremeyer, Barbara
Al-Lazikani, Bissan
Massie, Charlie
Greenman, Christopher
Ogden, Christopher
Verrill, Clare
Fisher, Cyril
Berney, Dan
Burns, Dan
Leongamornlert, Daniel
Jones, David
Nicol, David
Wedge, David
Cahill, Declan
Easton, Douglas
Rowe, Edward
Riabchenko, Ekaterina
Bancroft, Elizabeth
Mayer, Erik
Anokian, Ezequiel
Hamdy, Freddie
Park, Gahee
Pelvender, Gill
Leeman, Gregory
Gundem, Gunes
Zhang, Hongwei
Mills, Ian G.
Zhang, Jingjing
Teague, Jon
Zamora, Jorge
Karaszi, Katalin
Raine, Kieran
Matthews, Lucy
Stebbings, Lucy
Alexandrov, Ludmil B.
Marsden, Luke
Ahmed, Mahbubl
Nykter, Matti
Ghori, Mohammed
Livni, Naomi
Dennis, Nening
Van As, Nicholas
Camacho, Niedzica
Shah, Nimish
Kumar, Pardeep
Van Loo, Peter
Lach, Radoslaw
Edwards, Sandra
Pita, Sara
Field, Sarah J.
Thomas, Sarah
Tavaré, Simon
Scalabrino, Stefania
Hazell, Steven
McLaren, Stuart
Visakorpi, Tapio
Mitchell, Thomas J.
Dudderidge, Tim
Dadaev, Tokhir
McDermott, Ultan
Bo, Valeria
Haberland, Valeriia
Gnanapragasam, Vincent
Khoo, Vincent
Howat, William
Jie-Lu, Yong
Yu, Yongwei
Kote-Jarai, Zsofia
Martincorena, Iñigo
Bova, G. Steven
Foster, Christopher S.
Campbell, Peter
Maitland, Norman J.
Neal, David E.
Massie, Charlie E.
Lynch, Andy G.
Eeles, Rosalind A.
Cooper, Colin S.
Wedge, David C.
Brewer, Daniel S.
-
Funding
Funding for this research was provided by:
Prostate Cancer UK (TLD-S15-003, TLD-S15-003, TLD-S15-003)
Cancer Research UK (C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528, C5047/A29626/A22530/A17528)
- License Information
-
More Information
Article History
Received: 22 February 2022
Accepted: 17 August 2022
First Online: 22 September 2022
Declarations
:
: Ethical approval was obtained from the NHS East of England-Cambridge REC [03/018] and from the NHS Hull and East Yorkshire (REC ref/07/H1304/121) for the morphologically normal samples (including BPH) and fibroblasts, respectively. Samples were collected subject to ICGC standards of ethical consent ().
: The authors declare that they have no competing interests.
